Cigna reported $282.4B of revenue over the trailing twelve months, +7.8% on the year before. 11 reported series are charted on this page, each one as filed. Revenue, trailing twelve months: $282.4B (to Q2 2026). Net income: $6.98B, trailing twelve months to Q2 2026. Operating margin: 3.5%, trailing twelve months to Q2 2026. EPS: $24.19, trailing twelve months to Q2 2026.

CICigna

Healthcare

$282.35-2.2% 1Y

$282.35

$240.3252 weeks$305.80

CI as reported

Cigna reported $282.4B of revenue over the trailing twelve months, +7.8% on the year before. 11 reported series are charted on this page, each one as filed.

$282.4B

Revenue, trailing twelve months · to Q2 2026 · +7.8% against the twelve months before

Net income: $6.98B
Net income · +29% year on year · trailing twelve months to Q2 2026
Operating margin: 3.5%
Operating margin · trailing twelve months to Q2 2026
EPS: $24.19
EPS · +32% year on year · trailing twelve months to Q2 2026

Details›

Every series Ryufin has for CI, trailing twelve months
Series	Latest	Year on year	As of
Revenue	$282.4B	+7.8%	Q2 2026
Net income	$6.98B	+29%	Q2 2026
EPS	$24.19	+32%	Q2 2026
Gross margin	21%	n/a	Q2 2026
Operating margin	3.5%	n/a	Q2 2026
Net margin	2.5%	n/a	Q2 2026
ROE	16%	n/a	Q2 2026
ROA	4.2%	n/a	Q2 2026
ROIC	11%	n/a	Q2 2026
Free cash flow	$8.44B	n/a	Q4 2019 · 26 quarters behind
P/E	11.7	n/a	today

Every figure straight from the statements filed with the SEC, no scoring. Per-share figures and share counts are restated for stock splits, so a split never shows up as a collapse. Open a series for its full history.